3 hours Galectin Therapeutics Inc. (NASDAQ:GALT) Director Purchases $13,500.00 in StockMarketBeat
Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) Director Kevin D. Freeman bought 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 16th. The shares were acquired at an average price of $2.70 per share, wit…
X